TrialCancer2008

Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB).

Aminah Jatoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.